BACKGROUND: Informal care provides many benefits to cancer patients, but can be costly to caregivers. This study quantified the economic burden for informal caregivers of lung cancer (LC) and colorectal cancer (CRC) patients, examining differences by cancer type, phase of disease, stage at diagnosis, patient age, and relationship. METHODS: A cross-sectional survey of caregivers of LC and CRC patients participating in the Share Thoughts on Care survey was conducted. Economic burden was calculated using the opportunity cost of caregiver time, the value of work hours lost, and out-of-pocket expenditures. Factors associated with economic burden to caregivers were modeled using fixed-effects generalized least squares estimation. RESULTS: Informal caregivers (1,629) completed mailed surveys. Of these, 663, 822, and 144 were surveyed during the patient's initial phase (first year after diagnosis, not within 6 months of death), continuing phase (after 1 year, not within 6 months of death), and terminal phase (within 6 months of death) of disease, respectively. The accumulated economic burdens for caregivers were $7,028, $19,701, and $14,234 for those evaluated during the patient's initial phase, continuing phase, and terminal phase of disease, respectively. Economic burden was higher for caregivers of LC patients than CRC patients (p = .044) and for caregivers of patients diagnosed at stage 4 versus stage 1 (p = .001). Spouses faced higher economic burden than other relatives (p = .000) or friends (p = .000). CONCLUSIONS: Economic burden for informal caregivers of LC and CRC patients is substantial and should be included in estimates of the societal cost of cancer care.
BACKGROUND: Informal care provides many benefits to cancerpatients, but can be costly to caregivers. This study quantified the economic burden for informal caregivers of lung cancer (LC) and colorectal cancer (CRC) patients, examining differences by cancer type, phase of disease, stage at diagnosis, patient age, and relationship. METHODS: A cross-sectional survey of caregivers of LC and CRCpatients participating in the Share Thoughts on Care survey was conducted. Economic burden was calculated using the opportunity cost of caregiver time, the value of work hours lost, and out-of-pocket expenditures. Factors associated with economic burden to caregivers were modeled using fixed-effects generalized least squares estimation. RESULTS: Informal caregivers (1,629) completed mailed surveys. Of these, 663, 822, and 144 were surveyed during the patient's initial phase (first year after diagnosis, not within 6 months of death), continuing phase (after 1 year, not within 6 months of death), and terminal phase (within 6 months of death) of disease, respectively. The accumulated economic burdens for caregivers were $7,028, $19,701, and $14,234 for those evaluated during the patient's initial phase, continuing phase, and terminal phase of disease, respectively. Economic burden was higher for caregivers of LC patients than CRCpatients (p = .044) and for caregivers of patients diagnosed at stage 4 versus stage 1 (p = .001). Spouses faced higher economic burden than other relatives (p = .000) or friends (p = .000). CONCLUSIONS: Economic burden for informal caregivers of LC and CRCpatients is substantial and should be included in estimates of the societal cost of cancer care.
Authors: Kenneth M Langa; A Mark Fendrick; Michael E Chernew; Mohammed U Kabeto; Kerry L Paisley; James A Hayman Journal: Value Health Date: 2004 Mar-Apr Impact factor: 5.725
Authors: John Z Ayanian; Elizabeth A Chrischilles; Robert H Fletcher; Mona N Fouad; David P Harrington; Katherine L Kahn; Catarina I Kiefe; Joseph Lipscomb; Jennifer L Malin; Arnold L Potosky; Dawn T Provenzale; Robert S Sandler; Michelle van Ryn; Robert B Wallace; Jane C Weeks; Dee W West Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: J A Hayman; K M Langa; M U Kabeto; S J Katz; S M DeMonner; M E Chernew; M B Slavin; A M Fendrick Journal: J Clin Oncol Date: 2001-07-01 Impact factor: 44.544
Authors: Richard Schulz; Steven H Belle; Sara J Czaja; Kathleen A McGinnis; Alan Stevens; Song Zhang Journal: JAMA Date: 2004-08-25 Impact factor: 56.272
Authors: Eva Grunfeld; Doug Coyle; Timothy Whelan; Jennifer Clinch; Leonard Reyno; Craig C Earle; Andrew Willan; Raymond Viola; Marjorie Coristine; Teresa Janz; Robert Glossop Journal: CMAJ Date: 2004-06-08 Impact factor: 8.262
Authors: N Meunier-Beillard; N Ponthier; C Lepage; A Gagnaire; F Gheringuelli; L Bengrine; A Boudrant; L Rambach; V Quipourt; H Devilliers; Catherine Lejeune Journal: Support Care Cancer Date: 2018-06-05 Impact factor: 3.603